Role of integrin a5 in the development of aortic arch arteries.

  • Astrof, Sophie (PI)
  • ASTROF, SOPHIE (PI)
  • ASTROF, SOPHIE (PI)
  • ASTROF, SOPHIE (PI)

Project Details

Description

Congenital heart disease is the leading cause of infant mortality and morbidity in the developed world. The outflow vasculature of the heart is composed of aorta, pulmonary artery and a system of aortic arch arteries (AAAs) - proper development of this system is essential for the separation of venous and oxygenated blood and is required for human viability and health. Abnormal patterning of aortic arch arteries gives rise to severe birth defects and often occurs as a part of other congenital syndromes such as DiGeorge syndrome, one of the most common chromosome microdeletion syndromes in humans (1 in 4000 live births). Our long-term goal is to understand molecular and genetic pathways mediating normal AAA development in order to gain insight into the processes that go awry during pathological morphogenesis of the AAAs. Experiments in my laboratory led to the discovery that expression of integrin a5 in Isl1-positive cells and their descendants is required for the development of the aortic arch. We also found that integrin a5 is required for the presence of normal numbers of cardiac neural crest (CNC) cells in the pharyngeal arches. Since CNC cells give rise to vascular smooth muscle cells (VSMCs) of the AAAs and since normal formation, recruitment and association of VSMCs with aortic arch artery endothelial cells is required for the proper patterning of the AAAs, we propose to find out the role of integrin a5 in the development of the CNC cells and its descendants, VSMCs. Our specific aims will address three important questions about the function of integrin a5: a) what is the general role of integrin a5 in CNC development;b) how does the expression of integrin a5 in non-CNC cells affect the development of CNC and its derivatives;c) is integrin a5 required to facilitate growth factor signaling in the relevant pharyngeal arch cell types. To address these questions we propose the following three specific aims: I) To test the hypothesis that Itga5 is required to regulate survival and proliferation of the CNC progenitors;II) To test the hypothesis that expression of Itga5 in non-CNC cells is required for the formation and/or remodeling of AAAs;III) To determine the cellular and molecular mechanisms of Itga5 function during AAA development. Upon completion of this project, we will gain a significant insight into the function of integrin a5 in AAA development and into the normal process of AAA morphogenesis.
StatusFinished
Effective start/end date7/1/103/31/21

Funding

  • National Heart, Lung, and Blood Institute: $533,329.00
  • National Heart, Lung, and Blood Institute: $365,211.00
  • National Heart, Lung, and Blood Institute: $383,625.00
  • National Heart, Lung, and Blood Institute: $86,665.00
  • National Heart, Lung, and Blood Institute: $390,000.00
  • National Heart, Lung, and Blood Institute: $523,266.00
  • National Heart, Lung, and Blood Institute: $390,000.00
  • National Heart, Lung, and Blood Institute: $335,835.00
  • National Heart, Lung, and Blood Institute: $375,953.00
  • National Heart, Lung, and Blood Institute: $387,375.00
  • National Heart, Lung, and Blood Institute: $41,401.00
  • National Heart, Lung, and Blood Institute: $35,531.00

ASJC

  • Medicine(all)
  • Cardiology and Cardiovascular Medicine
  • Genetics
  • Molecular Biology

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.